Skip to main content
. 2022 Nov 17;13:1259–1270. doi: 10.18632/oncotarget.28310

Table 3. Exercise intervention significantly decreases fall rate in E4 carriers.

Fall rate per 1,000 participant-days1
Genotype Month N Mean fall rate Genotype Month N Mean fall rate
E2− B 109 3.47 E4− B 97 2.52
1 109 4.89 1 97 5.50
3 106 1.89 3 94 2.13
6 105 2.54 6 93 2.87
9 105 1.59 9 93 2.15
12 105 2.54 12 93 3.94
E2+ B 17 1.63 E4+ B 29 5.56
1 17 7.84 1 29 4.60
3 16 4.17 3 28 2.38
6 16 6.25 6 28 3.57
9 16 2.08 9 28 0*
12 16 6.25 12 28 0***

1Fall rate was calculated as (# participant-falls/# participant-days) × 1000. The fall rate of E4 carriers per 1000 participant-days decreased from 5.56 falls per 1000 participant days to 0 from baseline to month 12 (p = 0.043). There was a trend toward higher fall rate among E4 carriers versus E4 non-carriers at baseline (2.52 per 1000 participant-days versus 5.56, p = 0.059). However, after exercise intervention, E4 carriers demonstrated a significantly lower fall rate when compared with E4 non-carriers at both the 9 (2.15 versus 0, * p = 0.013) and 12 month (3.94 versus 0, *** p = 0.002) time periods. Abbreviation: B: baseline.